Literature DB >> 19710629

Hemodialysis access failure: a call to action--revisited.

Raymond M Hakim1, Jonathan Himmelfarb.   

Abstract

Eighty-two percent (82%) of patients initiating hemodialysis in the United States in 2006 did so with a catheter as the functioning access. Even in patients who have been followed by nephrologists for 6 months or more, 74% of patients initiated dialysis with a catheter. This is a multifactoral problem that requires attention and solutions from all stakeholders, including the nephrologist, the vascular surgeon, the hospital, and the insurance industry, as well as the patient and family. We propose a series of specific proposals that include a process for the timely referral and timely placement of a permanent access based on the patient's estimated or measured glomerular filtration rate (GFR), and a 'pay-for-performance' measure for vascular surgeons and nephrologists who admit patients with functional permanent accesses; such pay for performance would place a higher value for patients who are admitted with a functional arteriovenous (AV) fistula than for patients who are admitted with an AV graft. We also propose that hospitals develop a less permissive process for placement of PICC (peripherally inserted central catheters) lines in patients with GFR <60 ml/min and to consider surgery for access placement as 'urgent'. Finally, a more proactive educational process for patients and their families, including an 'informed non-consent' for patients who defer placement of a permanent access needs to be considered. The morbidity, mortality, and health-care costs associated with prolonged catheter use mandate urgent attention to this problem.

Entities:  

Mesh:

Year:  2009        PMID: 19710629     DOI: 10.1038/ki.2009.318

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Two-stage brachial-basilic transposition fistula provides superior patency rates for dialysis access in a safety-net population.

Authors:  Eduardo Gonzalez; Jeffry L Kashuk; Ernest E Moore; Stuart Linas; Angela Sauaia
Journal:  Surgery       Date:  2010-08-19       Impact factor: 3.982

2.  Vascular access for hemodialysis in older adults: a "patient first" approach.

Authors:  Ann M O'Hare
Journal:  J Am Soc Nephrol       Date:  2013-06-27       Impact factor: 10.121

Review 3.  The importance of success prediction in angioaccess surgery.

Authors:  Branko Fila; Saša Magaš; Predrag Pavić; Renata Ivanac; Marko Ajduk; Marko Malovrh
Journal:  Int Urol Nephrol       Date:  2016-05-18       Impact factor: 2.370

4.  Fistula First Initiative: Historical Impact on Vascular Access Practice Patterns and Influence on Future Vascular Access Care.

Authors:  Timmy Lee
Journal:  Cardiovasc Eng Technol       Date:  2017-07-10       Impact factor: 2.495

5.  Improving incident fistula rates: a process of care issue.

Authors:  Timmy Lee; Prabir Roy-Chaudhury; Charuhas V Thakar
Journal:  Am J Kidney Dis       Date:  2011-06       Impact factor: 8.860

6.  Arteriovenous graft placement in predialysis patients: a potential catheter-sparing strategy.

Authors:  Roman Shingarev; Ivan D Maya; Jill Barker-Finkel; Michael Allon
Journal:  Am J Kidney Dis       Date:  2011-04-02       Impact factor: 8.860

7.  Change in vascular access and hospitalization risk in long-term hemodialysis patients.

Authors:  Eduardo Lacson; Weiling Wang; J Michael Lazarus; Raymond M Hakim
Journal:  Clin J Am Soc Nephrol       Date:  2010-09-30       Impact factor: 8.237

8.  Functioning of an arteriovenous fistula requires heme oxygenase-2.

Authors:  Lu Kang; Joseph P Grande; Gianrico Farrugia; Anthony J Croatt; Zvonimir S Katusic; Karl A Nath
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-15

Review 9.  Balloon-assisted maturation (BAM) of the arteriovenous fistula: the good, the bad, and the ugly.

Authors:  Prabir Roy-Chaudhury; Timmy Lee; Ben Woodle; Davinder Wadehra; Begoña Campos-Naciff; Rino Munda
Journal:  Semin Nephrol       Date:  2012-11       Impact factor: 5.299

10.  Uremic serum and solutes increase post-vascular interventional thrombotic risk through altered stability of smooth muscle cell tissue factor.

Authors:  Vipul C Chitalia; Sowmya Shivanna; Jordi Martorell; Mercedes Balcells; Irene Bosch; Kumaran Kolandaivelu; Elazer R Edelman
Journal:  Circulation       Date:  2012-12-25       Impact factor: 29.690

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.